Pearl Jam Guitarist Mike McCready Discusses Battle with Crohn's Disease on Live Webcast
Pearl Jam Guitarist Mike McCready Discusses Battle with Crohn's Disease on Live Webcast
HealthTalk.com Hosts Live Webcast with Pearl Jam's Mike McCready on October 9, 2007 at 7:00 PM EDT/6:00 PM CT/4:00 PM PT
SEATTLE, Oct. 3 /PRNewswire/ -- HealthTalk.com, a leading health information web site for patients and caregivers, proudly presents a free educational Webcast with Crohn's patient and rock star Mike McCready.
"Imagine yourself playing music for thousands of screaming fans and you suddenly need to run offstage to go to the bathroom. This nightmare has been my reality many times," says Pearl Jam's lead guitarist Mike McCready. Find out how he slowed his flares by sacrificing his rock star habits in favor of exercise and eating right and biologic medicine. Get a positive and realistic perspective on life with Crohn's disease from someone who has been through it all.
Who/What/Where/When: Join our conversation online, broadcast live from the HealthTalk.com Studio, at 7:00 PM EDT/6:00 CT/4:00 PM PT on October 9, 2007, with Mike McCready as he shares his stories about life as a celebrity coping with Crohn's disease.
How to Register/Join: http://www.healthtalk.com/MIKE About HealthTalk
Healthtalk (http://www.healthtalk.com/) is a leading internet-based health information network for patients and caregivers living with a chronic condition. HealthTalk reaches over 500,000 community members each month. HealthTalk's mission is to inform and empower the nation's growing chronic care population by providing indispensable, hyper-relevant information and support through active communities, multi-media programming and advice from the nation's leading medical experts.
Contact: Patrick Aysseh, HealthTalk, (646) 358-1304, patricka@healthtalk.com
First Call Analyst:
FCMN Contact:
Source: HealthTalk
CONTACT: Patrick Aysseh of HealthTalk, +1-646-358-1304,
patricka@healthtalk.com
Web site: http://www.healthtalk.com/
Profile: International Entertainment
0 Comments:
Post a Comment
<< Home